Background: No surveys of stress ulcer prophylaxis prescribing in the USA h
ave been conducted since 1995. Since that time, the most comprehensive meta
-analysis and largest randomized study to date concerning stress ulcer prop
hylaxis have been published.
Results: Three hundred sixty-eight surveys were sent to all members of the
Section of Pharmacy and Pharmacology of the Society of Critical Care Medici
ne. One hundred fifty-three (42%) surveys were returned. Representatives fr
om 86% of institutions stated that medications for stress ulcer prophylaxis
are used in a majority (> 90%) of patients admitted to the intensive care
unit (ICU). Twenty-two per cent of institutions have recommendations for bo
th ICU and non-ICU settings. Fifty-eight per cent of institutions stated th
at there was one preferred medication for stress ulcer prophylaxis, and in
77% of these histamine-2-antagonists were the most popular.
Conclusions: There are wide variations in prescribing practices for stress
ulcer prophylaxis. Institutions should consult published literature and use
pre-existing guidelines as templates for developing their own guidelines.